News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Spectrum Pharmaceuticals, Inc.
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc.
July 20, 2023
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 17, 2023
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update
May 09, 2023
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update
March 22, 2023
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
March 17, 2023
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid Services
February 08, 2023
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Provides Update on ROLVEDON™ (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results
January 31, 2023
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Management Changes
January 04, 2023
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces New Employment Inducement Grants for Commercial Staff
December 27, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals’ ROLVEDON™ (eflapegrastim-xnst) Injection Added to NCCN Supportive Care Guidelines in Oncology for Hematopoietic Growth Factors
December 06, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for Poziotinib; Reaffirms Focus on the Commercialization of ROLVEDON™ (eflapegrastim-xnst) injection
November 25, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 10, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update
November 03, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Commercial Availability of ROLVEDON™ (eflapegrastim-xnst) Injection
October 21, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Debt Financing Agreement with SLR Capital Partners with $30 Million Funded at Closing
September 23, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022
September 10, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection
September 09, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2022
September 05, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 11, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
June 02, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response
May 26, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference
May 17, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 12, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Appoints Nora E. Brennan as Chief Financial Officer
May 11, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim
April 11, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Poster Presentation at the Upcoming AACR Annual Meeting
April 04, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update
March 17, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces an Oral Poziotinib Presentation at the Upcoming ESMO TAT 2022 Virtual Meeting
February 28, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
January 04, 2022
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
December 01, 2021
From
Spectrum Pharmaceuticals, Inc.
Via
Business Wire
Tickers
SPPI
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.